Mortality risk prediction in high-risk patients undergoing coronary artery bypass grafting: Are traditional risk scores accurate?
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | GONCHAROV, Maxim | |
dc.contributor.author | MEJIA, Omar Asdrubal Vilca | |
dc.contributor.author | ARTHUR, Camila Perez de Souza | |
dc.contributor.author | ORLANDI, Bianca Maria Maglia | |
dc.contributor.author | SOUSA, Alexandre | |
dc.contributor.author | OLIVEIRA, Marco Antonio Praca | |
dc.contributor.author | ATIK, Fernando Antibas | |
dc.contributor.author | SEGALOTE, Rodrigo Coelho | |
dc.contributor.author | TIVERON, Marcos Gradim | |
dc.contributor.author | SILVA, Pedro Gabriel Melo de Barros e | |
dc.contributor.author | NAKAZONE, Marcelo Arruda | |
dc.contributor.author | LISBOA, Luiz Augusto Ferreira | |
dc.contributor.author | DALLAN, Luis Alberto Oliveira | |
dc.contributor.author | ZHENG, Zhe | |
dc.contributor.author | HU, Shengshou | |
dc.contributor.author | JATENE, Fabio Biscegli | |
dc.date.accessioned | 2021-10-20T13:56:12Z | |
dc.date.available | 2021-10-20T13:56:12Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Background The performance of traditional scores is significantly limited to predict mortality in high-risk cardiac surgery. The aim of this study was to compare the performance of STS, ESII and HiriSCORE models in predicting mortality in high-risk patients undergoing CABG. Methods Cross-sectional analysis in the international prospective database of high-risk patients: HiriSCORE project. We evaluated 248 patients with STS or ESII (5-10%) undergoing CABG in 8 hospitals in Brazil and China. The main outcome was mortality, defined as all deaths occurred during the hospitalization in which the operation was performed, even after 30 days. Five variables were selected as predictors of mortality in this cohort of patients. The model's performance was evaluated through the calibration-in-the-large and the receiver operating curve (ROC) tests. Results The mean age was 69.90 +/- 9.45, with 52.02% being female, 25% of the patients were on New York Heart Association (NYHA) class IV and 49.6% had Canadian Cardiovascular Society (CCS) class 4 angina, and 85.5% had urgency or emergency status. The mortality observed in the sample was 13.31%. The HiriSCORE model showed better calibration (15.0%) compared to ESII (6.6%) and the STS model (2.0%). In the ROC curve, the HiriSCORE model showed better accuracy (ROC = 0.74) than the traditional models STS (ROC = 0.67) and ESII (ROC = 0.50). Conclusion Traditional models were inadequate to predict mortality of high-risk patients undergoing CABG. However, the HiriSCORE model was simple and accurate to predict mortality in high-risk patients. | eng |
dc.description.index | MEDLINE | eng |
dc.identifier.citation | PLOS ONE, v.16, n.8, article ID e0255662, 13p, 2021 | |
dc.identifier.doi | 10.1371/journal.pone.0255662 | |
dc.identifier.issn | 1932-6203 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/42099 | |
dc.language.iso | eng | |
dc.publisher | PUBLIC LIBRARY SCIENCE | eng |
dc.relation.ispartof | Plos One | |
dc.rights | openAccess | eng |
dc.rights.holder | Copyright PUBLIC LIBRARY SCIENCE | eng |
dc.subject.other | cardiac-surgery | eng |
dc.subject.other | euroscore ii | eng |
dc.subject.other | society | eng |
dc.subject.other | validation | eng |
dc.subject.other | outcomes | eng |
dc.subject.other | performance | eng |
dc.subject.other | models | eng |
dc.subject.other | impact | eng |
dc.subject.wos | Multidisciplinary Sciences | eng |
dc.title | Mortality risk prediction in high-risk patients undergoing coronary artery bypass grafting: Are traditional risk scores accurate? | eng |
dc.type | article | eng |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
dspace.entity.type | Publication | |
hcfmusp.affiliation.country | China | |
hcfmusp.affiliation.countryiso | cn | |
hcfmusp.author.external | ARTHUR, Camila Perez de Souza:Beneficencia Portuguesa Sao Paulo, Dept Cardiovasc Surg, Sao Paulo, Brazil | |
hcfmusp.author.external | SOUSA, Alexandre:Beneficencia Portuguesa Sao Paulo, Dept Cardiovasc Surg, Sao Paulo, Brazil | |
hcfmusp.author.external | OLIVEIRA, Marco Antonio Praca:Beneficencia Portuguesa Sao Paulo, Dept Cardiovasc Surg, Sao Paulo, Brazil | |
hcfmusp.author.external | ATIK, Fernando Antibas:Inst Cardiol Dist Fed, Dept Cardiovasc Surg, Brasilia, DF, Brazil | |
hcfmusp.author.external | SEGALOTE, Rodrigo Coelho:Inst Nacl Cardiol Rio De Janeiro, Dept Cardiovasc Surg, Rio De Janeiro, Brazil | |
hcfmusp.author.external | TIVERON, Marcos Gradim:Hosp Santa Casa Misericordia Marilia, Dept Cardiovasc Surg, Marilia, SP, Brazil | |
hcfmusp.author.external | SILVA, Pedro Gabriel Melo de Barros e:Hosp Samaritano Paulista, Dept Cardiovasc Surg, Sao Paulo, Brazil | |
hcfmusp.author.external | NAKAZONE, Marcelo Arruda:Hosp Base Sao Jose Rio Preto, Dept Cardiovasc Surg, Sao Jose Do Rio Preto, Brazil | |
hcfmusp.author.external | ZHENG, Zhe:Fuwai Hosp, Dept Cardiovasc Surg, Beijing, Peoples R China | |
hcfmusp.author.external | HU, Shengshou:Fuwai Hosp, Dept Cardiovasc Surg, Beijing, Peoples R China | |
hcfmusp.citation.scopus | 2 | |
hcfmusp.contributor.author-fmusphc | MAXIM GONCHAROV | |
hcfmusp.contributor.author-fmusphc | OMAR ASDRUBAL VILCA MEJIA | |
hcfmusp.contributor.author-fmusphc | BIANCA MARIA MAGLIA ORLANDI | |
hcfmusp.contributor.author-fmusphc | LUIZ AUGUSTO FERREIRA LISBOA | |
hcfmusp.contributor.author-fmusphc | LUIS ALBERTO OLIVEIRA DALLAN | |
hcfmusp.contributor.author-fmusphc | FABIO BISCEGLI JATENE | |
hcfmusp.description.articlenumber | e0255662 | |
hcfmusp.description.issue | 8 | |
hcfmusp.description.volume | 16 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 34343224 | |
hcfmusp.origem.scopus | 2-s2.0-85111823321 | |
hcfmusp.origem.wos | WOS:000685264200044 | |
hcfmusp.publisher.city | SAN FRANCISCO | eng |
hcfmusp.publisher.country | USA | eng |
hcfmusp.relation.reference | Akkerhuis KM, 2000, EUR HEART J, V21, P371, DOI 10.1053/euhj.1999.1743 | eng |
hcfmusp.relation.reference | Barili F, 2013, ANN THORAC SURG, V95, P1539, DOI 10.1016/j.athoracsur.2013.01.058 | eng |
hcfmusp.relation.reference | Silva PGMDE, 2015, REV BRAS CIR CARDIOV, V30, P660, DOI 10.5935/1678-9741.20150075 | eng |
hcfmusp.relation.reference | Englum BR, 2015, ANN THORAC SURG, V99, P856, DOI 10.1016/j.athoracsur.2014.09.048 | eng |
hcfmusp.relation.reference | Lisboa LAF, 2014, REV BRAS CIR CARDIOV, V29, P1, DOI 10.5935/1678-9741.20140004 | eng |
hcfmusp.relation.reference | Grant SW, 2013, CIRC-CARDIOVASC QUAL, V6, P178, DOI 10.1161/CIRCOUTCOMES.111.000018 | eng |
hcfmusp.relation.reference | Gutacker N, 2015, EUR J PUBLIC HEALTH, V25, P28, DOI 10.1093/eurpub/cku228 | eng |
hcfmusp.relation.reference | Howell NJ, 2013, EUR J CARDIO-THORAC, V44, P1006, DOI 10.1093/ejcts/ezt174 | eng |
hcfmusp.relation.reference | Hu Z, 2020, ANN THORAC SURG, V109, P1234, DOI 10.1016/j.athoracsur.2019.08.020 | eng |
hcfmusp.relation.reference | Kappetein AP, 2012, EUR J CARDIO-THORAC, V41, P732, DOI 10.1093/ejcts/ezs061 | eng |
hcfmusp.relation.reference | Lapar DJ, 2014, J THORAC CARDIOV SUR, V148, P2686, DOI 10.1016/j.jtcvs.2014.06.086 | eng |
hcfmusp.relation.reference | McNeely C, 2016, ANN THORAC SURG, V102, P132, DOI 10.1016/j.athoracsur.2016.01.016 | eng |
hcfmusp.relation.reference | Nashef SAM, 2002, EUR J CARDIO-THORAC, V22, P101, DOI 10.1016/S1010-7940(02)00208-7 | eng |
hcfmusp.relation.reference | Nashef SAM, 2012, EUR J CARDIO-THORAC, V41, P734, DOI 10.1093/ejcts/ezs043 | eng |
hcfmusp.relation.reference | Neumann FJ, 2019, EUR HEART J, V40, P79, DOI 10.1093/eurheartj/ehy855 | eng |
hcfmusp.relation.reference | Palma-Ruiz M, 2003, REV ESP CARDIOL, V56, P687, DOI 10.1157/13049651 | eng |
hcfmusp.relation.reference | Ranucci M, 2016, J CARDIOTHORAC SURG, V11, DOI 10.1186/s13019-016-0405-3 | eng |
hcfmusp.relation.reference | Ranucci M, 2009, EUR J CARDIO-THORAC, V36, P791, DOI 10.1016/j.ejcts.2009.02.023 | eng |
hcfmusp.relation.reference | Schrutka L, 2019, EUR J CARDIO-THORAC, V56, P534, DOI 10.1093/ejcts/ezz040 | eng |
hcfmusp.relation.reference | Sergeant P, 2001, EUR J CARDIO-THORAC, V20, P1176, DOI 10.1016/S1010-7940(01)01013-2 | eng |
hcfmusp.relation.reference | Sergeant P, 2012, EUR J CARDIO-THORAC, V41, P729, DOI 10.1093/ejcts/ezs057 | eng |
hcfmusp.relation.reference | Shahian DM, 2019, J THORAC CARDIOV SUR, V158, P110, DOI 10.1016/j.jtcvs.2018.12.072 | eng |
hcfmusp.relation.reference | Shahian DM., 2009, ANN THORAC SURG, V88, pS2, DOI [10.1016/j.athoracsur.2009.05.053, DOI 10.1016/j.athoracsur.2009.05.053] | eng |
hcfmusp.relation.reference | Shih T, 2015, ANN THORAC SURG, V100, P516, DOI 10.1016/j.athoracsur.2015.02.085 | eng |
hcfmusp.relation.reference | Tu JV, 1997, J AM COLL CARDIOL, V30, P1317, DOI 10.1016/S0735-1097(97)00295-7 | eng |
hcfmusp.relation.reference | Mejia OAV, 2012, REV BRAS CIR CARDIOV, V27, P503, DOI 10.5935/1678-9741.20120091 | eng |
hcfmusp.relation.reference | Mejia OAV, 2012, REV BRAS CIR CARDIOV, V27, P187, DOI 10.5935/1678-9741.20120033 | eng |
hcfmusp.relation.reference | Yamaoka H, 2016, J CARDIOL, V68, P135, DOI 10.1016/j.jjcc.2015.08.017 | eng |
hcfmusp.scopus.lastupdate | 2024-06-16 | |
relation.isAuthorOfPublication | c87c70f6-c475-4306-a062-a049502b39cf | |
relation.isAuthorOfPublication | 1211382f-dcaf-4d5e-89fc-7184fa642cf0 | |
relation.isAuthorOfPublication | db4cf202-7c6f-4676-9e2c-1e864613b44e | |
relation.isAuthorOfPublication | 6dfd66ac-8f10-4c77-afc2-a2af59d8d24b | |
relation.isAuthorOfPublication | 698c7026-2a3e-4e9a-a3c3-32fa96f7f4b4 | |
relation.isAuthorOfPublication | 8af24ebc-578b-4192-8ea4-643cb9cd2377 | |
relation.isAuthorOfPublication.latestForDiscovery | c87c70f6-c475-4306-a062-a049502b39cf |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- art_GONCHAROV_Mortality_risk_prediction_in_highrisk_patients_undergoing_coronary_2021.PDF
- Tamanho:
- 954.68 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)